" class="no-js "lang="en-US"> Axol Bioscience - Medtech Alert
Sunday, August 03, 2025
Axol Bioscience | Pharmtech Focus

Axol Bioscience

About Axol Bioscience

Axol Bioscience

Axol Bioscience is the leading provider of product and service solutions within the induced pluripotent stem cell (iPSC)-based neuroscience, immune cell, and cardiac modeling for drug discovery and screening markets. Our custom research capabilities in gene editing, electrophysiology, reprogramming, and differentiation means we can offer customers validated ready-to-use cell lines and a suite of services bolstered by deep scientific expertise and robust functional data – all with short lead times.

Related Story

Axol Bioscience Collaborates with StrataStem to Deliver Stem Cell-Based ‘Clinical Trial in a Dish’ for Alzheimer’s Disease

June 7 2023

Axol Bioscience, a leading pluripotent stem cell technology provider for drug discovery has signed an […]

Axol Bioscience Introduces CiPA-validated Human Stem Cell-derived Ventricular Cardiomyocytes to Help Improve Drug Discovery

June 8 2022

Axol Bioscience Ltd. (Axol), an established provider of iPSC-derived cells, media, and characterization services for life science […]